// App-Quantinova.ai

2346 : Chemokine Ligand 9 (CXCL9) [Monokine Induced By Gamma Interferon (MIG)]  As a Predictor of Active Disease Status in Localized Scleroderma

Researchers

Presenter

  • Kathryn S. Torok

Principal Investigators

  • Qi Mi

  • Emily Mirizio

  • Kaila Schollaert-Fitch

  • Mark Fritzler

  • Marvin J. Fritzler

Medical Centers

  • Pediatrics/Neonatology, University of Pittsburgh Medical Center, Pittsburgh, PA

  • Department of Sports Medicine and Nutrition, University of Pittsburgh, Pittsburgh, PA

  • Pediatrics/Neonatology, University of Pittsburgh Medical Center, Pittsburgh, PA

  • Eve Technologies, Calgary, AB, Canada

  • Internal Medicine, University of Calgary, Calgary, AB, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • C-X-C motif chemokine ligand 9

  • Interferon-gamma

  • Interferon

Drug/Treatment

  • Interferon

  • Interferon Gamma

  • IFN-lambda

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved